Investor relations

Our Investor Relations activities are in accordance with the transparency rules of the German Corporate Governance Code. We pursue comprehensive, timely, and open communication with private and institutional investors as well as financial analysts. The equal treatment of all market actors is very important to us in our day-to-day communication.

In 2009, we intensified our dialogue with the capital market in order to enable investors and analysts to make a fair assessment of Fresenius Group’s business situation and market conditions. In addition to the annual analysts’ meeting and the quarterly conference calls / webcasts, Fresenius also made presentations in important financial markets in Europe and the United States. Regular contacts were further extended at 17 international investor conferences, 17 roadshows, and numerous one-on-one meetings with institutional investors and analysts. In collaboration with banks, we also conducted so-called field trips, where we combine tours of our production facilities for investors and analysts with discussions with the Management Board.

We also continued dialogue with our private investors. The internet is an important tool for us in this regard. Our private shareholders can follow live webcasts of the quarterly conference calls and annual analysts’ meeting on our website at www.fresenius.com. Presentations can be downloaded shortly before and, of course, after the events in the Investor Relations section under ‘Presentations’. We also publish all presentations given at international investor conferences. We intend to make further improvements in the ways we communicate with private shareholders and would welcome any suggestions you may care to make. In 2010, we also plan to increase the information content of our website.

In 2009, we received important commendations for the standard of our financial communications. In the competition for the best annual report conducted by the German business magazine manager magazin, which analyzed about 200 annual reports published by German and European companies, we placed 10th in the DAX category and 13th in the overall ranking. In addition, we again received the Platinum Award for our annual report in the category ‘Health Care – Equipment & Supplies’ from the League of American Communications Professionals (LACP). Fresenius ranked 100th in the overall rating for all categories. More than 3,500 companies from over 20 countries took part in this contest. Fresenius SE’s online annual report also won the Gold Award at the LACP 2009 spotlight awards in the EMEA & Asia-Pacific category. In 2009, the jury consisting of communications experts from different sectors and functions reviewed a total of more than 1,000 online annual reports. The jury was particularly impressed by the strict conceptual layout of the content, the appealing digital design, and the numerous flash elements, which gave the report a dynamic, interactive structure.

If you would like to contact us or find out about key dates in our financial calendar 2010, please take a look at the last page of this report or visit us at www.fresenius.com in the section ‘Investor Relations’.

Key data of the Fresenius shares


  2009 2008 2007 2006 2005
1 Xetra closing prices on the Frankfurt Stock Exchange.
2 Adjusted for share split.
3 Total number of ordinary and preference shares multiplied by the respective Xetra year-end quotation on the Frankfurt Stock Exchange.
4 Fresenius preference share (source: Bloomberg)
5 Proposal
6 Adjusted for special items resulting from changes in the market value (mark-to-market accounting) of the Mandatory Exchangeable Bonds (MEB) and Contingent Value Rights (CVR) in connection with the acquisition of APP Pharmaceuticals.
7 Before special items relating to the APP acquisition.
Number of shares 161,315,376 161,143,734 155,164,770 51,451,292 50,722,280
Ordinary shares 80,657,688 80,571,867 77,582,385 25,725,646 25,361,140
Preference shares 80,657,688 80,571,867 77,582,385 25,725,646 25,361,140
           
Stock exchange quotation ordinary share 1 in €          
High 43.76 60.87 63.35 51.32 2 36.38 2
Low 27.69 31.93 50.17 35.47 2 25.19 2
Year-end quotation 43.45 36.23 56.00 50.57 2 35.33 2
Stock exchange quotation preference share 1 in €          
High 50.01 59.25 63.12 55.32 2 39.83 2
Low 31.40 37.23 50.70 37.41 2 22.97 2
Year-end quotation 50.01 41.59 56.90 54.27 2 38.22 2
           
Market capitalization 3 in million € 7,538 6,270 8,759 8,091 5,596
           
Beta factor 4 0.29 0.85 0.80 0.88 0.74
           
Total dividend distribution in million € 121.8 5 113.6 103.2 88.8 75.8
           
Per share in €          
Dividend ordinary share 0.75 5 0.70 0.66 0.57 0.49 2
Dividend preference share 0.76 5 0.71 0.67 0.58 0.50 2
Earnings per ordinary share 3.18 6 2.85 7 2.64 2.15 2 1.76 2
Earnings per preference share 3.19 6 2.86 7 2.65 2.16 2 1.77 2

  2009 2008 2007 2006 2005
1 Xetra closing prices on the Frankfurt Stock Exchange.
2 Adjusted for share split.
3 Total number of ordinary and preference shares multiplied by the respective Xetra year-end quotation on the Frankfurt Stock Exchange.
4 Fresenius preference share (source: Bloomberg)
5 Proposal
6 Adjusted for special items resulting from changes in the market value (mark-to-market accounting) of the Mandatory Exchangeable Bonds (MEB) and Contingent Value Rights (CVR) in connection with the acquisition of APP Pharmaceuticals.
7 Before special items relating to the APP acquisition.
Number of shares 161,315,376 161,143,734 155,164,770 51,451,292 50,722,280
Ordinary shares 80,657,688 80,571,867 77,582,385 25,725,646 25,361,140
Preference shares 80,657,688 80,571,867 77,582,385 25,725,646 25,361,140
           
Stock exchange quotation ordinary share 1 in €          
High 43.76 60.87 63.35 51.32 2 36.38 2
Low 27.69 31.93 50.17 35.47 2 25.19 2
Year-end quotation 43.45 36.23 56.00 50.57 2 35.33 2
Stock exchange quotation preference share 1 in €          
High 50.01 59.25 63.12 55.32 2 39.83 2
Low 31.40 37.23 50.70 37.41 2 22.97 2
Year-end quotation 50.01 41.59 56.90 54.27 2 38.22 2
           
Market capitalization 3 in million € 7,538 6,270 8,759 8,091 5,596
           
Beta factor 4 0.29 0.85 0.80 0.88 0.74
           
Total dividend distribution in million € 121.8 5 113.6 103.2 88.8 75.8
           
Per share in €          
Dividend ordinary share 0.75 5 0.70 0.66 0.57 0.49 2
Dividend preference share 0.76 5 0.71 0.67 0.58 0.50 2
Earnings per ordinary share 3.18 6 2.85 7 2.64 2.15 2 1.76 2
Earnings per preference share 3.19 6 2.86 7 2.65 2.16 2 1.77 2

Continue reading:
Business segments

QUICKFINDER

External related links